AMA on X: “A new option for children w/ sickle cell disease w/ recurrent VOC or T…” | PeekX

Skip to content

Viewer Video downloader Blog

A fast, private reader for public X posts. No account, no tracking, no pop-ups.

Viewer

X / Twitter viewer View without an account Profile viewer Media viewer Reply viewer Thread reader Nitter alternative Bookmarklet

Download

Video downloader Twitter to MP4 Twitter to MP3 Image downloader GIF downloader

About

How it works Blog Privacy Terms Copyright / DMCA

Language:English Español Português 日本語

PeekX is an independent tool and is not affiliated with, endorsed by or sponsored by X Corp. “X” and “Twitter” are trademarks of their respective owners. We only show posts that their authors made public and never access private or protected accounts. Downloaded media belongs to its creators — please respect their rights.

Username or post link

Home / @AmerMedicalAssn / Post

@AmerMedicalAssn

A new option for children w/ sickle cell disease w/ recurrent VOC or TDT: the FDA expanded approval for CRISPR gene-editing therapy CASGEVY to eligible patients age 2+, down from age 12+. It uses the child's own blood stem cells, no donor match is needed. 1/3

Sep 30, 2026, 12:09 PM UTC

3 14

More from @AmerMedicalAssn

Downloads

This post has no photos or videos. You can still save it as an image or copy its text below.

Save & share

Turn this post into a clean image, or copy it as text or Markdown.

AMA on X: “A new option for children w/ sickle cell disease w/ recurrent VOC or T…” | PeekX